Replace. Restore. Reimagine.
BlueRock Therapeutics (bluerocktx.com) scores 73 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 33rd percentile of 11687 Healthcare brands.
BlueRock Therapeutics is a clinical-stage biotechnology company focused on cell and gene therapy. Its mission is to transform disease treatment by using cellular medicine to replace cells damaged or lost to disease. The company targets patients with significant unmet medical needs and works with clinicians, researchers, and healthcare partners to develop innovative cellular therapies. BlueRock positions itself as a science-driven leader in next-generation cell therapy development.
| Brand Name | BlueRock Therapeutics |
|---|---|
| Domain | bluerocktx.com |
| Industry | Healthcare |
| Main Competitors | Vertex Pharmaceuticals (88/100), bluebird bio (57/100), CRISPR Therapeutics (79/100), Fate Therapeutics, Editas Medicine (82/100), Sana Biotechnology, Sarepta Therapeutics (83/100) |
Moz Domain Authority 42/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,545,923 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Transforming disease treatment through cell and gene therapy. Join us at BlueRock to discover our cutting-edge science & clinical programs." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, GitHub; no detected presence on Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is BlueRock Therapeutics?", Claude could identify the brand as of September 2026. BlueRock Therapeutics is a clinical-stage biotechnology company focused on developing engineered cell therapies derived from induced pluripotent stem cells (iPSCs) to treat degenerative diseases, including neurological conditions like Parkinson's disease. It was acquired by Bayer Best known for Developing iPSC-derived cell therapies for Parkinson's disease, notably its program bemdaneprocel.
When asked "Best brands similar to BlueRock Therapeutics?", Claude would recommend BlueRock Therapeutics as of September 2026. It's a notable name in the regenerative medicine and cell therapy space, especially for stem-cell-based treatments, so it would come up in discussions of leaders in that field.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
BlueRock Therapeutics's main competitors in Healthcare: Vertex Pharmaceuticals (88/100), bluebird bio (57/100), CRISPR Therapeutics (79/100), Editas Medicine (82/100), Sarepta Therapeutics (83/100).
Sources: Brand Analyzer scan
BlueRock Therapeutics has limited AI-search visibility, scoring 26/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 46, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: BlueRock Therapeutics official site
BlueRock Therapeutics scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: BlueRock Therapeutics official site
BlueRock Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: BlueRock Therapeutics official site
BlueRock Therapeutics is a clinical-stage cell and gene therapy company dedicated to transforming disease treatment through cellular medicine. It develops therapies designed to replace cells that have been damaged or lost due to disease, targeting conditions with significant unmet medical needs.
Sources: BlueRock Therapeutics official site
BlueRock Therapeutics develops cell and gene therapies aimed at replacing cells damaged or lost to disease. The company conducts scientific research and runs clinical programs to bring these next-generation cellular medicines to patients, collaborating with clinicians, researchers, and healthcare partners in the process.
Sources: BlueRock Therapeutics official site
BlueRock Therapeutics' work is intended for patients suffering from diseases with significant unmet medical needs. Additionally, its research and clinical programs involve clinicians, researchers, and healthcare partners interested in advanced cell and gene therapy solutions.
Sources: BlueRock Therapeutics official site
BlueRock Therapeutics scores 26/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
BlueRock Therapeutics has a weak AI-visibility profile at 26/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #1,545,923 (Tranco), a Moz Domain Authority of 42/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify BlueRock Therapeutics from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to BlueRock Therapeutics: BioPlus Specialty Pharmacy (73/100), Bioplatforms Australia (73/100), BMUS (British Medical Ultrasound Society) (73/100), BookJane (73/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.